This content is from: Portfolio China’s Sluggish M&A Market Will Likely Stay Slow in 2022 Recent expansionary policies are unlikely to fix the mergers and acquisitions market in China, according to a Natixis report. By Hannah Zhang December 07, 2021
This content is from: Premium Nuvation Bio Flounders After EcoR1 SPAC Merger In just five days the shares of the biopharma company that merged with Oleg Nodelman’s blank check company fell by more than one-third. By Stephen Taub March 31, 2021
This content is from: Premium Another Newly Merged SPAC Is Getting Mauled. Here’s Why Hedge Fund Investors Aren’t Worried. Cano Health, backed by Suvretta, Third Point, and others, has been on the decline since merging with Jaws Acquisition in early June. By Stephen Taub June 30, 2021
This content is from: Corner Office M&A Hit Highs Last Year. 2022 Could Be Even Bigger. “The trends we are seeing in this very active market indicate that we are just at the start of the next M&A run,” said Deloitte’s Trevear Thomas. By Jessica Hamlin January 12, 2022
This content is from: Premium Two Hedge Funds Poised to Benefit From a SPAC Deal Worth $1.6 Billion Sarissa and Perceptive stands to benefit from Pear Therapeutics’ merger with Pritzker-backed blank check company. By Stephen Taub June 22, 2021
This content is from: Corner Office Ultra-Low Interest Rates Are Driving Insurers Into the Arms of Private Equity Cerulli Associates expects to see more private equity mergers and acquisitions in the insurance industry as a result of the pandemic. By Amy Whyte September 17, 2020
